Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P skin fibroblasts |
Human immortalized skin fibroblasts (patient derived) | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C. Benincá et al., J. Med. Genet., 2021, 58: 155–167, doi:10.1136/jmedgenet-2020-106861 | Link | ||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Cogoi et al., Nucleic Acids Res., Apr 2013; 41: 4049 - 4064 | Link | |
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link | |
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | X. Wu et al., PNAS, Nov 2016, 113: E6965 - E6973 | ||
PC-12 |
Rat adrenal gland cell line | ATCC CRL-1721 | Rat | other | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | F. Martorana et al., Cell Death and Disease, 2018, 9:391; DOI 10.1038/s41419-018-0429-9 | Link | |
PC-12 |
Rat adrenal gland cell line | ATCC CRL-1721 | Rat | other | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | A. Morch, Dissertation, 2019, Ernst-Moritz-Arndt Universität Greifswald | ||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Werwein et al., Nucleic Acids Res., 2019, 47(1): 103–121, doi: 10.1093/nar/gky935 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Steinmann et al., J. Biol. Chem., Vol. 288, No. 31, pp. 22257–22269, August 2, 2013 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., BMC Cancer, 2014, 14:921, doi:10.1186/1471-2407-14-921 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | application note | ![]() |
||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | U. Weirauch et al., Nucleic Acid Therapeutics, 2013, 23 (4): 264-272, DOI: 10.1089/nat.2012.0407 | Link | |
Phoenix |
Retrovirus producer cell line (Derivat of 293T) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Dossena et al., J. Biol. Chem., Nov 2011; 286: 40659 - 40670 | Link | ||
Phoenix |
Retrovirus producer cell line (Derivat of 293T) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | E. Bernardinelli et al., PLOSONE, doi.org/10.1371/journal.pone.0179591 | Link | ||
RAW 264.7 |
Mouse leukaemic monocyte/macrophage cell line | ATCC TIB-71 | Mouse | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Xu et al., Journal of Proteomics, 2015, 128: 30-38; doi.org/10.1016/j.jprot.2015.07.003 | ||
RAW 264.7 |
Mouse leukaemic monocyte/macrophage cell line | ATCC TIB-71 | Mouse | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Kim et al, J. Immunol., May 2015; 194: 4498 - 4506 | Link | |
rHTC |
Rat hepatoma cell line | Rat | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ullio et al., J. of Lipid Res., 2012, 53: 1134–1143, DOI 10.1194/jlr.M022384 | Link | ||
RKO |
Human colon carcinoma cell line | ATCC CRL-2577 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | |
RPE-J |
Rat retinal pigment epithelial cell line | ATCC CRL-2240 | Rat | sensory organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | Y. Mao et al., Mol. Biol. Cell, Mar 2012; 23: 1104 - 1114 | Link | |
RPE-J |
Rat retinal pigment epithelial cell line | ATCC CRL-2240 | Rat | sensory organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | Y. Dun et al., Free Radical Biology and Medicine, 2013, 65: 1340–1351, doi.org/10.1016/j.freeradbiomed.2013.10.006 | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Cell Death and Disease, 2013, 4: e578, doi:10.1038/cddis.2013.109 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | |||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Clinical and Translational Medicine, 2014, 3:1, doi:10.1186/2001-1326-3-1 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2015, 28; 442-452; doi: 10.1111/pcmr.12378 | |||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | ||
SAN |
Human lymphonodal melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | F. Albano et al., Biochimie, 2012, DOI: 10.1016/j.biochi.2012.12.012 |